Small molecule myristate inhibitors of Bcr-abl and methods of use
US11254682B2 · kind B2 · utility
0Cited by
3References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 20, 2020 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Jul 20, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides novel heteroaryl compounds of formula (IV). Such compounds are useful for the treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.